[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Dacima Consulting\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":95},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,69],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100587908","tunisian-lung-cancer-study-100587908",false,"NCT06934499","Tunisian Lung Cancer Study","Clinical Observational Study on Tunisian Lung Cancer","LUNG-TUN","Inclusion Criteria:\n\n* Age more than 18 years\n* Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and\u002For by cytology, at least 3 months before the inclusion date\n* Informed consent\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":20,"type":21},1334,"ESTIMATED","12 Months","OBSERVATIONAL","This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.",[26],"Pulmonary Cancer",[26,28,29],"Registry","Tunisia","RECRUITING","2025-06-02",{"date":33,"type":34},"2025-06-04","ACTUAL",{"date":36,"type":34},"2025-05-02",{"date":38,"type":21},"2026-10-30",{"name":40,"class":41},"Dacima Consulting","OTHER",2,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":51,"targetDuration":53,"studyType":23,"phases":4,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":4},"100579533","the-prevalence-of-prediabetes-in-primary-care-medicine-in-tunisia-100579533","NCT06825533","The Prevalence of Prediabetes in Primary Care Medicine in Tunisia","The Prevalence of Prediabetes in Primary Care Medicine in Tunisia. a National Descriptive Cross-Sectional Study","TUN-PREDIAB","Inclusion Criteria:\n\n* Ambulatory patient consulting in primary care in a public or private structure\n\nExclusion Criteria:\n\n* Known diabetes\n* Concomitant medication that may influence blood sugar (corticosteroids, metformin, GLP1 analogues, SGLT2 inhibitor)\n* Severe, acute or chronic comorbidity (end-stage renal failure, severe liver disease, heart failure)\n* Severe anemia\n* Pregnancy",{"count":52,"type":21},5000,"1 Day","The study is national, observational and cross-sectional and aims to estimate the prevalence of prediabetes in primary care in Tunisia.",[56],"Prediabetes",[56,58,59],"STMGF","Survey","NOT_YET_RECRUITING","2025-02-23",{"date":63,"type":34},"2025-02-25",{"date":65,"type":21},"2025-04-21",{"date":67,"type":21},"2025-08-21",{"name":40,"class":41},{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":76,"targetDuration":53,"studyType":23,"phases":4,"briefSummary":78,"conditions":79,"keywords":82,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},"100550281","tunisian-clinical-registry-on-hypoparathyroidism-and-pseudo-hypoparathyroidism-100550281","NCT06445036","Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism","THYPARS","Inclusion Criteria:\n\n* Hypoparathyroidism defined by low serum calcium \\\u003C 2.2 mmol\u002Fl (\\\u003C 88 mg\u002Fl) associated with inadequate PTH (low or normal) and normal creatinine\n\nExclusion Criteria:\n\n* Cervical surgery \\\u003C 6 months.\n* Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism.\n* Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc.\n* Familial hypocalcemia hypercalciuria.\n* Pseudo-pseudo-hypoparathyroidism.",{"count":77,"type":21},1000,"Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.",[80,81],"Hypoparathyroidism","Pseudo Hypoparathyroidism",[80,81,83,84,85],"Clinical Registry","Endocrinology","Parathyroid gland","2025-02-20",{"date":88,"type":34},"2025-02-21",{"date":90,"type":21},"2025-02-27",{"date":92,"type":21},"2025-07-27",{"name":40,"class":41},1,""]